HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validationKi Hong Kim, Youn Soo Jeon, Hee Jo Yang et al.|Cancer Treatment and Research Communications|2026Cited by 0